Search

B Introduction: b Although norepinephrine is the first-line vasopressor for the management of septic shock, some studies have shown definite clinical benefits with vasopressin as initial therapy. However, vasopressin may be superior to norepinephrine in the requirement of kidney replacement therapy in patients with septic shock. However, the patients in the vasopressin group had lower odds of the requirement of Kidney replacement therapy as compared to the norepinephrine group(OR, 0.68; CI, 0.47-0.98; I SP 2 sp = 0%). [Extracted from the article]

B Conclusions: b ECMO improved 30 days mortality and 90 days mortality outcomes in patients with ARDS. Thus, ECMO offers a mortality benefit in ARDS refractory to conventional management. B Introduction: b We conducted this systematic review and meta-analysis to compare the effects of ECMO in mortality rates, length of hospital stay, and adverse clinical outcomes in patients with ARDS to that of conventional management. [Extracted from the article]

B Introduction: b There is limited evidence around the clinical significance of the endotracheal tube (ETT) size selection in patients with status asthmaticus who require invasive ventilation. B Conclusions: b This study reports incrementally higher mortality in patients with status asthmaticus who had received incrementally smaller ETT sizes. B Results: b We enrolled patients from 1,111 status asthmaticus admissions: Six point six percent (74) had a 7.0 mm or smaller ETT (ETT7 group), 16.6% (184) a 7.5 mm ETT (ETT7.5 group), 16.7% (163) an 8.0 mm or larger ETT (ETT8 group), and 62.1% (690) were not intubated. [Extracted from the article]